Knight Therapeutics Inc (GUD) Common Stock NPV

Sell:8.14 CADBuy:8.18 CADPrice decreased0.08 CAD (0.97%)

Market closed |
Prices delayed by at least 15 minutes
Sell:8.14 CAD
Buy:8.18 CAD
Change:Price decreased0.08 CAD (0.97%)
Market closed |
Prices delayed by at least 15 minutes
Sell:8.14 CAD
Buy:8.18 CAD
Change:Price decreased0.08 CAD (0.97%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
14 May 2026
Robert Nathaniel LandeIndependent Director
Sell
Regular sell transaction (market)
20,0008.39 CAD167,800.00 CAD223,178
14 May 2026
Robert Nathaniel LandeIndependent Director
Sell
Regular sell transaction (market)
20,0008.40 CAD168,000.00 CAD203,178
13 April 2026
James C (Jim) GaleChairman of the Board
Sell
Option/Award related
24,4097.57 CAD184,750.00 CAD52,997
10 April 2026
Michael Joseph TremblayDirector
Sell
Option/Award related
20,0007.58 CAD151,600.00 CAD2,000
6 April 2026
Robert Nathaniel LandeIndependent Director
Sell
Option/Award related
20,0007.65 CAD153,000.00 CAD243,178
26 March 2026
Cristiane Zanqueta Coelho PeevOther Manager
Sell
Tax related
4,9387.09 CAD35,010.42 CAD9,724
23 March 2026
Henrique José Dos Santos DiasVice President
Sell
Option/Award related
3,8166.54 CAD24,956.64 CAD16,000
23 March 2026
Henrique José Dos Santos DiasVice President
Sell
Tax related
3,8676.54 CAD25,290.18 CAD12,133
15 March 2026
Jonathan Ross GoodmanExecutive Chairman
Buy
Regular purchase transaction
2115.30 CAD1,118.30 CAD990,413
15 March 2026
Jonathan Ross GoodmanExecutive Chairman
Buy
Regular purchase transaction
9026.17 CAD5,565.34 CAD990,202

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
13 April 2026
James C (Jim) GaleChairman of the Board
Sell
Option/Award related
24,4097.57 CAD184,750.00 CAD52,997
14 May 2026
Robert Nathaniel LandeIndependent Director
Sell
Regular sell transaction (market)
20,0008.40 CAD168,000.00 CAD203,178
14 May 2026
Robert Nathaniel LandeIndependent Director
Sell
Regular sell transaction (market)
20,0008.39 CAD167,800.00 CAD223,178
6 April 2026
Robert Nathaniel LandeIndependent Director
Sell
Option/Award related
20,0007.65 CAD153,000.00 CAD243,178
10 April 2026
Michael Joseph TremblayDirector
Sell
Option/Award related
20,0007.58 CAD151,600.00 CAD2,000

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.